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TubulinVoltage dependent anion channels (VDAC) are highly conserved proteins that are responsible for permeabil-
ity of the mitochondrial outer membrane to hydrophilic metabolites like ATP, ADP and respiratory substrates.
Although previously assumed to remain open, VDAC closure is emerging as an important mechanism for reg-
ulation of global mitochondrial metabolism in apoptotic cells and also in cells that are not dying. During he-
patic ethanol oxidation to acetaldehyde, VDAC closure suppresses exchange of mitochondrial metabolites,
resulting in inhibition of ureagenesis. In vivo, VDAC closure after ethanol occurs coordinately with mitochon-
drial uncoupling. Since acetaldehyde passes through membranes independently of channels and trans-
porters, VDAC closure and uncoupling together foster selective and more rapid oxidative metabolism of
toxic acetaldehyde to nontoxic acetate by mitochondrial aldehyde dehydrogenase. In single reconstituted
VDAC, tubulin decreases VDAC conductance, and in HepG2 hepatoma cells, free tubulin negatively modulates
mitochondrial membrane potential, an effect enhanced by protein kinase A. Tubulin-dependent closure of
VDAC in cancer cells contributes to suppression of mitochondrial metabolism and may underlie the Warburg
phenomenon of aerobic glycolysis. This article is part of a Special Issue entitled: VDAC structure, function, and
regulation of mitochondrial metabolism.
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1.1. Voltage dependent anion channels
Voltage dependent anion channels (VDAC) are highly conserved
proteins in the mitochondrial outer membrane (MOM) with three
isoforms in mice and humans: VDAC1, 2 and 3, each of a molecular
mass of about 30 kDa [12,23,74]. VDAC forms a barrel in the bilayer
comprised of a transmembrane alpha helix and 13 (or more) trans-
membrane beta strands. This beta barrel encloses an aqueous channel
of ~3 nm in internal diameter, which in the open state allows passage
of non-electrolytes up to 5 kDa in size, althoughmolecularweight is not
the only determinant of permeance through VDAC. Similarmodels with
additional beta strands have also been proposed, including recently
published 3D structures of a 19-stranded β barrel, but these results
have been challenged [7,25,29,39,82].
Except for a relatively few membrane-permeant lipophilic com-
pounds, metabolites that enter and leave mitochondria must cross
MOM through VDAC [23]. VDAC shows both ion selectivity and volt-
age dependence. In the open state, anions are favored over cations,
but this selectivity is actually weak. Positive and negative membrane
potentials (ΔΨ) close VDAC symmetrically with half maximal closure
at ±50 mV.Whether ΔΨ is a physiological regulator of VDAC conduc-
tance remains a matter of conjecture, since in the closed state VDAC
becomes a cation selective pore of 1.8 nm in diameter that still con-
ducts small cations, such as K+, Na+ and Ca2+, as well as Cl−,
whose movement through VDAC collapses electrical potentials [77].
One possibility is that a Donnan potential may form across the outer
membrane that is large enough to gate VDAC [77]. Donnan potentials
result from asymmetric distribution of impermeant charged species
across a membrane, typically proteins. However, the issue is contro-
versial because charged macromolecules reside on both sides of the
outer membrane. Moreover, high ionic strength of the intracellular
milieuwould be also expected to decrease themagnitude of any Donnan
potentials forming to below that causing VDAC to close. Nonetheless, a
report of a ΔpH across the outer membrane supports the existence of a
Donnan potential of ~−40 mV, close to a gating potential for VDAC
[65]. Metabolism-driven ﬂuxes of charged metabolites are unlikely to
contribute signiﬁcantly to outer membrane potential formation, since
such ﬂuxes are limited by transporters in the inner membrane and are
typically at least 2 orders of magnitude less than the ﬂux of small ions
through VDAC even in its closed state. Nonetheless, VDAC closure
when it occurs would be expected to block movement of major anionic
metabolites, including respiratory substrates, creatine phosphate, ATP,
ADP and Pi during oxidative phosphorylation [67].
Each mammalian VDAC isoform confers permeability in liposomes
with a similar molecular weight cutoff, but electrophysiological stud-
ies show differences. VDAC1 and VDAC2 have prototypic voltage gat-
ing, but VDAC2 also has a second discrete lower conductance and ion
selective state. VDAC3, by contrast, does not show clear voltage de-
pendency (reviewed in [27]). Superresolution microscopy revealsthat VDAC1 and VDAC2 colocalize in distinct clusters in mitochondria
of osteosarcoma cells, whereas VDAC3 is uniformly distributed [61].
In the past, the assumption has generally been that VDAC is open
during normal metabolism to allow free diffusion of metabolites
across MOM. In this view, MOM simply serves as a scaffold enclosing
the mitochondrial inner membrane (MIM). Recent data, however,
suggests that VDAC has the ability to close and inhibit exchange of
metabolites between the cytosol and mitochondria [28,41,48,84].
For example, VDAC appears to close relatively early in the evolution
of apoptosis with the consequence that mitochondria no longer re-
lease ATP to the cytosol or take up ADP, Pi and respiratory substrates
[84]. Our evidence also indicates that VDAC closes after acute ethanol
treatment of hepatocytes and in cancer cells displaying aerobic gly-
colysis (Warburg phenomenon) [41,48,52] (see below). VDAC con-
ductance is regulated by a variety of factors, including hexokinase,
bcl2 family members, protein kinase A (PKA), glycogen synthase 3β
(GSK3β), protein C kinase ε (PKCε), NADH (which increases after etha-
nol exposure) and possibly others [3,4,45,66,85,86].
2. VDAC and ethanol metabolism
2.1. Alcoholic liver disease
Alcoholic liver disease (ALD) affects more than 2.5 million people in
the U.S. alone. Heavy drinking causes ALD, but many heavy drinkers
may never experience hepatic symptoms, although in patients with
chronic hepatitis C infection, even moderate alcohol drinking causes he-
patic cirrhosis and end stage liver disease. Single alcohol binges produce
little liver injury except for reversible hepatic steatosis (fatty liver)
[11,46,51,63]. Hepatic steatosis without alcohol abuse (non-alcoholic
fatty liver disease, NAFLD) occurs in association with the metabolic syn-
drome,whose features include obesity, insulin resistance, type 2diabetes
and hypertension, which can progress to nonalcoholic steatohepatitis
(NASH), cirrhosis and liver failure [19,22,91]. Remarkably, the histopa-
thology of NADLD/NASH and ALD is indistinguishable with features of
ballooning degeneration, apoptosis and necrosis of hepatocytes, necroin-
ﬂammatory foci with neutrophilic inﬁltration, and hyaline inclusions
(Mallory bodies). Steatohepatitis virtually identical to ALD also occurs
from occupational exposure of non-obese, non-drinking industrial
workers to vinyl chloride, a substance metabolized in the liver to chlor-
oacetaldehyde (ClAcAld), an example of toxicant-associated steatohepa-
titis (TASH) [21].
2.2. Hepatic alcohol metabolism
Ethanol is metabolized predominantly by the liver and undergoes
two-step oxidation ﬁrst to acetaldehyde (AcAld) and then to acetate
(Fig. 1) [15]. Alcohol dehydrogenase (ADH), cytochrome P450 2E1
(CYP450 2E1) and catalase in the cytosol, endoplasmic reticulum and
peroxisomes, respectively, catalyze the ﬁrst oxidation step, which
Fig. 1. Metabolism of ethanol. See text for details.
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is quantitatively themost important ﬁrst step enzyme, CYP450 2E1me-
tabolism is noteworthy in producing reactive oxygen species (ROS)
[50]. Aldehyde dehydrogenase (ALDH) catalyzes the further oxidation
of AcAld to acetate. Of 19 knownmammalianALDHgenes,mitochondri-
al ALDH2 with high afﬁnity for AcAld (Kmb1 μM) is most important for
AcAld oxidation (and detoxiﬁcation) to acetate [53]. Together, ADH and
ALDH form two moles of NADH for each mole of ethanol oxidized to
acetate. For ethanol oxidation to continue, NADHmust be oxidized back
to NAD+ by mitochondrial respiration.
2.3. Swift increase of alcohol metabolism
Ethanol ingestion produces an adaptive increase of hepatic ethanol
metabolism called swift increase of alcohol metabolism (SIAM)
[57,88], which occurs in as little as 2.5 h after a single bolus dose of eth-
anol (e.g., 5 g/kg i.g. in rats) [79,92]. Since ethanol oxidation is obligato-
rily linked to NAD+ supply, mitochondrial respiration causing NADH
oxidation also nearly doubles in SIAM. Although increasedmitochondri-
al oxygen consumption should in theory lead to increased ATP genera-
tion by oxidative phosphorylation, to the contrary ethanol treatment
actually decreases hepatic ATP, stimulates glycolysis and depletes gly-
cogen stores. Furthermore, mitochondrial β-oxidation of fatty acids be-
comes inhibited, promoting fat accumulation within hepatocytes
(steatosis) [16,73]. Overall, SIAM is an adaptive response by the liver
to oxidize ethanol more rapidly. The mitochondrial respiratory burst,
in particular, promotes more rapid elimination of toxic AcAld by ALDH
and increases NAD+ supply for ADH-dependent ethanol metabolism.
Neither ethanol oxidation by CYP450 nor hepatic ADH activity is altered
when SIAM ﬁrst develops [92], but SIAM is partially blocked by
3-aminotriazole (AT), a CyP450 inhibitor, and more fully blocked by
4-methylpyrazole (MP), an ADH inhibitor [78]. However, AT also in-
hibits catalase, and other studies suggest that catalase may play a role
in SIAM [14,16]. Adrenergic hormones release free fatty acids from adi-
pose tissue, which serve as substrates for long-chain fatty acid peroxi-
somal β-oxidation. The ensuing peroxisomal H2O2 formation then can
promote catalase-dependent alcohol metabolism.
2.4. Mitochondria and fatty liver disease
Hepatic ethanol metabolism, AcAld formation and oxidative stress
are generally accepted as important initiators of ALD. Among the ear-
liest manifestations of hepatocyte injury by alcohol are morphological
and functional abnormalities of mitochondria [46]. Chronic ethanol
treatment selectively depletes the mitochondrial antioxidant GSH
[30]. AcAld is toxic to mitochondria and aggravates oxidative stress
by binding to GSH and promoting GSH leakage [49]. NADH overproduc-
tion triggered by ethanol oxidation may also promote mitochondrial
production of ROS. Impairment of oxidative phosphorylation and devel-
opment of megamitochondria after ethanol are possibly related to lipid
peroxidation [56]. Alcohol also causes oxidative mitochondrial DNA(mtDNA) damage [40], and mtDNA deletions that occur in 85% of alco-
holic patients with steatosis may impair mitochondrial β-oxidation of
fatty acids [32,33]. Exposure of cultured hepatocytes to ethanol causes
formation of ROS, onset of the mitochondrial permeability transition
(MPT) and apoptosis [2]. Overexpression of human CYPP450 2E1 in
HepG2 hepatoma cells promotes ethanol-induced MPT onset and apo-
ptosis, effects that are prevented by CYP450 2E1 inhibitors, antioxidants
and the MPT inhibitor cyclosporin A (CsA) [20]. Ethanol-induced mito-
chondrial damage likely impairs ATP production and thus may enhance
hepatic susceptibility to alcohol-induced centrolobular hypoxia [31].
Likewise in NASH, similar mitochondrial dysfunction seems to occur
leading to impaired fatmetabolism, overproduction of ROS, lipid perox-
idation and cell death [71].
2.5. Hypothesis that closure of voltage dependent anions channels
contributes to the swift increase of alcohol metabolism
How SIAM leads to enhanced mitochondrial respiration while si-
multaneously depleting ATP and inhibiting mitochondrial β-oxidation
remains unknown. Here, we review data in support of the hypothesis
that a relative closure of VDAC underlies many of themetabolic adapta-
tions occurring in SIAM. By inhibiting entry of normal respiratory sub-
strates like pyruvate and fatty acyl-CoA, VDAC closure allows the
selective and more rapid oxidation of toxic AcAld, since AcAld crosses
mitochondrial membranes freely without need for a transporter or
channel. Although beneﬁcial in promoting detoxiﬁcation of aldehydes,
VDAC closure has the potential of becoming maladaptive by promoting
ATP depletion and steatosis.
2.6. Decreased mitochondrial outer membrane permeability in ethanol-
treated hepatocytes
VDAC is the only channel known that allows hydrophilic metabo-
lites to crossMOM in normal viable cells. By contrast, themitochondrial
protein import apparatus is speciﬁc for polypeptides, and the Bax/Bak-
dependent cytochrome c release channel opens irreversibly only after
activation of apoptotic pathways [69,76]. To assess changes of MOM
permeability after ethanol, rat hepatocytes were ﬁrst treated with eth-
anol and then exposed to a low concentration of digitonin, which selec-
tively permeabilizes (skins) the plasma membrane to allow entry of
adenine nucleotides and exogenous respiratory substrates like succi-
nate [41]. In such skinned hepatocytes, ethanol pretreatment decreased
succinate-supported respiration and suppressed accessibility of ADP to
adenylate kinase in the mitochondrial intermembrane space (IMS)
(Fig. 2). MOM permeabilization with high digitonin overcame these ef-
fects and restored respiration and adenylate kinase activity to that of
skinned hepatocytes not pretreated with ethanol. Moreover in skinned
hepatocytes not treatedwith ethanol, MOMpermeabilizationwith high
digitonin did not produce an additional increase of succinate oxidation
or adenylate kinase activity. These results are consistent with the con-
clusion that MOM permeability to hydrophilic metabolites decreases
after ethanol treatment and becomes rate-limiting for mitochondrial
metabolism.
MOM permeability was also independently assessed by confocal
microscopy from entrapment of 3 kDa rhodamine-dextran (RhDex)
in mitochondria of mechanically permeabilized hepatocytes [41,48].
Hepatocyteswere ﬁrst loadedwithMitoTracker Green, which covalently
labels mitochondria with green ﬂuorescence, and then incubated with
3 kDa RhDex in an artiﬁcial intracellular buffer (ICB). The plasma mem-
braneswere then torn open by drawing amicropipette tip across the he-
patocytes. Because 3 kDa is below the size exclusion limit of VDAC
[24,26,75], added RhDex entered the IMS provided, of course, that
VDAC was open. After RhDex entry, 4,4′-diisothiocyano-2,2′-stilbenedi-
sulfonic acid (DIDS), an inhibitor of anion channels including VDAC
[8,24,75], was added to close VDAC and entrap RhDex within the IMS.
The cells were then washed with ICB containing DIDS but no RhDex.
Fig. 2. Ethanol limits and suppresses respiration and accessibility to adenylate kinase in
the mitochondrial intermembrane space. In A, succinate-supported respiration of
untreated and ethanol-treated rat hepatocytes was measured before and after sequen-
tial addition of 8 and 80 μM digitonin to permeabilize the plasma membrane and MOM,
respectively. Plasmalemmal permeabilization allowed entry of succinate and stimulation
of respiration, which was less in ethanol-treated hepatocytes. After MOM permeabiliza-
tion with high digitonin, respiration of ethanol-treated and untreated hepatocytes was
not different. In B, untreated and ethanol-treated rat hepatocytes were exposed to 8 μM
digitonin, centrifuged and resuspended to remove cytosolic enzymes. AK was measured
with and without 80 μM digitonin to permeabilize MOM, as indicated. After ethanol, AK
was decreased. Suppression of AK activity was restored by high digitonin, which showed
that AK inhibition was due to decreased access of substrates for AK into the IMS.
Adapted from [41].
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extracellular space and cytosol but was retained by MTG-labeled mito-
chondria and to a lesser extent by endosomes and nuclei (Fig. 3). In
this procedure, ﬂuorescent RhDex freely enters the IMS of mitochondria
with open VDAC to be entrapped after DIDS treatment, but as VDAC
closes less RhDex can enter the IMS and become entrapped. Using this
procedure, ethanol decreased RhDex entrapment in mitochondria byFig. 3. Decreased entry of 3 kDa rhodamine-dextran into the mitochondrial intermem-
brane space after ethanol treatment. Hepatocytes were pretreated with vehicle (Con-
trol) or 50 mM ethanol subjected to a RhoDex entrapment protocol. Note that
ethanol pretreatment decreases mitochondrial retention of red-ﬂuorescing RhoDex.
Adapted from [41].35% compared to untreated hepatocytes (Fig. 3) [41]. Overall, these re-
sults demonstrate that acute ethanol exposure decreases mitochondrial
outer membrane permeability most likely by inhibition of VDAC.
2.7. Suppression by ethanol of ureagenic respiration in cultured rat
hepatocytes
In hepatocytes, ureagenesis comprises a sequence of biochemical re-
actions occurring in separate intracellular compartments— themitochon-
drial matrix and cytosol [90]. Ureagenesis is highly energy-requiring, and
fourmoles of high energy phosphate are required to synthesize onemole
of urea fromammonia and bicarbonate precursors. In particular, ureagen-
esis requires ﬂux of ornithine, citrulline, adenine nucleotides, respiratory
substrates and other metabolites across MOM into and out of mitochon-
dria. Thus, if VDAC were to begin to close after ethanol, ureagenesis
would be one of the ﬁrst mitochondrial processes to be affected. Indeed,
ethanol suppresses ureagenesis by isolated perfused rat livers, an effect
associated with decreased hepatic ATP levels [1]. In cultured rat hepato-
cytes, respirationnearly doubled inparallelwith increasedurea formation
after addition of ureagenic substrates (Fig. 4). Ethanol dose-dependently
inhibited the stimulation of respiration by ureagenic substrates (urea-
genic respiration), but ethanol did not inhibit uncoupled respiration or
basal respiration [41,42]. Half maximal suppression of respiration stimu-
lated by ureagenic substrates occurred at ~50 mM ethanol, and as little
as 10 mM ethanol had a clear effect (Fig. 4). These concentrations are
comparable to those for ethanol entering the liver via the portal vein in
drinkers. Ethanol also inhibited urea formation in proportion to the inhi-
bition of ureagenic respiration. Suppression of ureagenic respiration by
ethanol was partially reversed by inhibitors of ADH, CYP450 2E1 and
catalase. By contrast, ALDH inhibition enhanced suppression of urea-
genic respiration. These observations were consistent with the conclu-
sion that AcAld was responsible, at least in part, for ethanol-induced
suppression of ureagenesis.
2.8. Suppression of ureagenic respiration by exogenous acetaldehyde
When exogenous AcAld was added to cultured hepatocytes, urea-
genic respiration was inhibited with half maximal inhibition at
~100 μM after correction for evaporative loss of the volatile AcAld,
but AcAld did not inhibit uncoupled respiration (Fig. 4) [42]. Other alde-
hydes, such as MDA and ClAcAld, also inhibited ureagenic respiration
with half maximal inhibition of 5 and 250 μM, respectively (uncor-
rected for evaporation). MDA was a particularly strong inhibitor of
ureagenic respiration, but did not inhibit uncoupled respiration. Taken
together, these ﬁndings support the conclusion that ethanol oxidation
to AcAld underlies ethanol-dependent suppression of ureagenic respi-
ration and that other aldehydes can produce similar effects. Since etha-
nol oxidation causes oxidative stress via CYP450 2E1 metabolism,Fig. 4. Suppression of ureagenic respiration by ethanol and acetaldehyde. Respiration
by cultured rat hepatocytes was measured before and after sequential addition of urea-
genic substrates (NH4Cl, ornithine, lactate) and KCN, as indicated, in the presence and
absence of ethanol (left panel) or acetaldehyde (right panel). Note inhibition of respi-
ration by ethanol and acetaldehyde.
Adapted from [42].
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To verify directly that AcAld decreasesMOMpermeability, uptake of
RhDex into the IMS was assessed in skinned hepatocytes. AcAld
(500 μM, uncorrected for evaporation) prevented RhDex entrapment
to an even greater extent than ethanol pretreatment [42]. Since VDAC
conductance solely determines the permeability of the MOM to
RhDex, this experiment provides direct evidence that AcAld causes
VDAC closure,which likely explains inhibition of ureagenesis by ethanol
and AcAld.
2.9. Ethanol-induced mitochondrial depolarization in vivo
VDAC closure induced by ethanol metabolism promotes selective
oxidation of AcAld and helps explain ATP depletion and steatosis
after ethanol, since VDAC closure blocks mitochondrial ATP release
and uptake of fatty acids required for β-oxidation. The VDAC hypoth-
esis also accounts for why rats fed short and medium chain fatty acids
in their diet do not develop steatosis after ethanol treatment [60],
since short and medium chain fatty acids cross mitochondrial mem-
branes freely without using the carnitine shuttle or other transporter
system [6]. However, VDAC closure cannot explain the stimulation of
mitochondrial respiration in SIAM. Indeed, inhibition of uptake of cy-
tosolic ADP would be expected to suppress respiration that is ordinar-
ily stimulated by ADP. These considerations imply an additional
mitochondrial adaptation to ethanol, namely mitochondrial uncou-
pling to cause futile dissipation of the protonmotive force and respira-
tory stimulation [48].
Such respiratory stimulation does not occur in vitro in hepatocytes
treated with ethanol, consistent with observations that the respiratory
burst of SIAM is an in vivo response to ethanol that does not occur in iso-
lated systems. To better characterize hepatic mitochondrial responses
to acute ethanol treatment in vivo, intravital confocal/multiphoton mi-
croscopy was performed on the livers of anesthetized mice. After a sin-
gle intragastric dose of ethanol (up to 6 g/kg), mitochondria
depolarized within hepatocytes in an all-or-nothing fashion in as little
1 h, as shown by lack of uptake of ΔΨ-indicating ﬂuorophores like rho-
damine 123 and tetramethylrhodamine methylester (TMRM) [93].
Ethanol-induced mitochondrial depolarization was dose- and time-
dependent, maximally affecting more than 90% of hepatocytes and
peaking after 6 to 12 h of the ethanol dosing [93]. After 24 h, mitochon-
dria of most hepatocytes recovered normal polarization, and after a
week the livers appeared entirely normal. Necrotic and apoptotic cell
deathwasminimal throughout. The time course of ethanol-inducedmi-
tochondrial depolarization mirrored that for SIAM reported previously.
In mitochondria of hepatocytes and most eukaryotic cells, NADH
autoﬂuorescence arises primarily from mitochondria, whereas cyto-
solic NADH ﬂuorescence is quenched [62]. NAD+ is nonﬂuorescent.
After ethanol treatment in vivo, intravital multiphoton microscopy
revealed a decrease of NADH autoﬂuorescence speciﬁcally in hepato-
cytes with depolarized mitochondria and not in hepatocytes with po-
larized mitochondria. With respiratory inhibition, such as that caused
by anoxia, NADH ﬂuorescence increases and NAD+ decreases, where-
as the opposite occurs after mitochondrial uncoupling. Thus, mito-
chondrial depolarization occurring with oxidation of NADH after in
vivo ethanol treatment signiﬁed an uncoupling event rather than anox-
ia or respiratory inhibition. Mitochondrial depolarization was linked to
ethanol metabolism to AcAld, since mitochondrial depolarization after
ethanol was decreased in rodents deﬁcient in alcohol dehydrogenase
or CYP2E1. Moreover activation of ALDH decreased depolarization,
whereas ALDH inhibition enhanced depolarization [94].
Overall, these ﬁndings are consistent with the conclusion that eth-
anol has two rapid effects on mitochondria. The ﬁrst is a relative clo-
sure of VDAC, and the second is opening a protonophoric uncoupling
circuit that dissipates mitochondrial ΔΨ and stimulates respiration.
Together these changes promote rapid and selective mitochondrialoxidation of acetaldehyde. Nonetheless, future studies are needed to
determine the mechanisms underlying AcAld-mediated VDAC closure
and protonophoric uncoupling. AcAld may not be the only aldehyde
causing these effects, and aldehydes like MDA produced after lipid
peroxidation and ClAcAld formed during vinyl-chloride metabolism
may produce similar VDAC closure and mitochondrial uncoupling.
The aldehyde-dependent disruptions of normal mitochondrial func-
tioning may be an early common effect leading to the virtually iden-
tical pathologies of ALD, NASH and TASH.
3. Voltage dependent anion channels and Warburg metabolism in
cancer cells
3.1. Warburg phenomenon
As recognized by Otto Warburg 75 years ago, malignant cancer
cells display high rates of glycolysis even when fully oxygenated
[36,89]. Ordinarily, cells with mitochondria metabolize glucose to py-
ruvate, which is further oxidized to CO2 and H2O by the tricarboxylic
acid cycle and mitochondrial respiratory chain. In this aerobic metab-
olism, glycolysis accounts for only about 5% of ATP production with
the remainder produced by oxidative phosphorylation. In cancer
cells, however, high glycolytic rates and net formation of lactate persist
despite adequate oxygenation, a fact fully conﬁrmed in cancer patients
by positron emission tomography of the glucose analog 18ﬂuorodeoxy-
glucose [35]. Consequently, glycolysis accounts for 50 to 70% of ATP for-
mation in tumor cells [55,83].
The advantage of aerobic glycolysis to tumor cells remains amatter of
conjecture. Enhanced glycolytic capacity may be beneﬁcial for tumors
whose rapid growth often exceeds their blood and hence oxygen supply.
Furthermore, although glycolysis is less efﬁcient, glycolysismay still pro-
duce ATP faster than oxidative phosphorylation to support more rapid
growth, an advantage to rapidly proliferating cells, especially in an hyp-
oxic environment [38]. Additionally, glycolytic intermediates are needed
as precursors for anabolic biosynthesis by proliferating cells. The War-
burg phenomenon ismore than an epiphenomenon, since pharmacolog-
ic interventions to promote oxidative phosphorylation and/or inhibit
glycolysis (e.g., dichloroacetic acid, 3-bromopyruvate) cause tumor cell
death both in vitro and in vivo [55,58].
Aerobic glycolysis in cancer cells is associated with increased expres-
sion of hexokinase (HK), especially theHK-2 isoform, and plasmalemmal
glucose transporters (e.g., GLUT1) [18,37]. AlthoughWarburg suggested
that aerobic glycolysis in tumor cells might be the consequence of a de-
fect in what we now know is mitochondrial oxidative phosphorylation,
studies show that isolated tumor mitochondria are fully functional
with regards to respiration and ATP synthesis [59]. The mystery persists
as to why fully functional mitochondria inside tumor cells are nonethe-
less relatively inactive in terms of respiration and ATP generation.
A preference for glycolysis also occurs for yeast growing aerobically
on glucose. When glucose and oxygen are plentiful, yeast cells prefer
glucose fermentation to aerobic respiration even though aerobic respi-
ration represents a much more efﬁcient use of glucose. Only after glu-
cose is exhausted does a so-called diauxic shift occur, at which time
new enzymes are expressed for aerobic mitochondrial metabolism of
fermentation products like ethanol [34]. However, growth rates after
the diauxic shift are slower. The preference in yeast for aerobic glycoly-
sis is analogous to theWarburg phenomenon and indicates that aerobic
glycolysis supports more rapid cell proliferation, a selective growth ad-
vantage for both yeast and cancer cells [34,83].
3.2. Voltage dependent anion channels, tubulin and protein kinases
Nanomolar dimeric tubulin closes VDAC reconstituted into planar
phospholipid bilayers and appears to decrease MOM permeability to
adenine nucleotides in isolated brain mitochondria and permeabi-
lized synaptosomes and cardiac myocytes [68,81]. These effects of
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nase A (PKA) [72]. Puriﬁed VDAC1 is a substrate for PKA in vitro,
and PKA phosphorylation of VDAC inhibits association of VDAC with
other proteins, such as Bax and tBid [5,10], where tBid but not Bax
causes VDAC closure [66]. By contrast, VDAC2 phosphorylation by
GSK3β appears to promote channel opening [28]. In isolated rat liver
mitochondria, PKA phosphorylation inhibits onset of the MPT, an effect
possibly associated with phosphorylation of VDAC [64].
3.3. VDAC hypothesis for suppression of mitochondrial metabolism in the
Warburg phenomenon
Much research on cancer cell metabolism and the Warburg phe-
nomenon focuses on enhancement of glycolysis, and mechanisms un-
derlying suppression of mitochondrial metabolism in cancer cells
have received less attention. Previously, we proposed that relative
but not absolute VDAC closure occurs in mitochondria of cancer
cells [48]. Such VDAC closure limits exchange of mitochondrial me-
tabolites and globally suppresses mitochondrial metabolism in favor
of glycolysis. Here, we review recent data that high levels of free tubulin
in cancer cells are responsible for this VDAC closure and that protein ki-
nase signaling pathways, such as those involving PKA and GSK3β, fur-
ther modulate tubulin-dependent VDAC closure.
3.4. Maintenance of mitochondrial membrane potential through both
respiration and ATP hydrolysis in HepG2 cells
Myxothiazol (10 μM), a Complex III respiratory inhibitor, caused
little change of mitochondrial polarization to HepG2 human hepato-
ma cells, as assessed by uptake of the potential—indicating cationic
ﬂuorophore, TMRM. Only after addition of oligomycin, an inhibitor
of the F1F0-ATP synthase, was TMRM released, signifyingmitochondri-
al depolarization [52]. These results illustrate that ATP from other
sources, such as glycolysis, can maintain mitochondrial ΔΨ in the
presence of respiratory inhibition by reversal of the F1F0-ATP synthase.
By contrast, when oligomycin was added before myxothiazol, mito-
chondria hyperpolarized and only depolarized when myxothiazol was
added subsequently. Hyperpolarization after oligomycin in the absence
of respiratory inhibitor signiﬁed that respiration was driving ATP for-
mation, because oligomycin reverses the depolarizing effect of ATP syn-
thesis on ΔΨ. Overall, these results show that both respiration and ATP
hydrolysis can support mitochondrial polarization in HepG2 cells.
3.5. Rotenone, colchicine and nocodazole decrease mitochondrial membrane
potential
Rotenone, a Complex I inhibitor, should in theory exert changes very
much like myxothiazol. However, when HepG2 cells were exposed to
rotenone, they depolarized quickly [52]. Rotenone also caused cellular
rounding unlike myxothiazol which did not. In previous studies, rote-
none depolymerizedmicrotubules [17,54]. Accordingly, two structural-
ly unrelatedmicrotubule destabilizers, colchicine and nocodazole, were
examined for their effect on mitochondrial ΔΨ. Both caused mitochon-
drial depolarization and cell rounding to a similar extent as rotenone
(Fig. 5). Thus, each structurally distinct microtubule destabilizer caused
mitochondrial depolarization. To assess whether mitochondrial depo-
larization depended speciﬁcally on increased free tubulin inside cells,
HepG2 cells were exposed to the microtubule stabilizer, paclitaxel
[43,44]. In contrast to the depolarizing effect of colchicine, rotenone
and nocodazole, paclitaxel hyperpolarized mitochondria. Moreover,
paclitaxel prevented mitochondrial depolarization when the HepG2
cells were subsequently treated with rotenone, colchicine or nocoda-
zole (Fig. 5). In parallel, depolymerized (free) to polymerized tubulin
ratios were assessed using a Western blot procedure. As expected, the
microtubule-depolymerizing agents, colchicine, nocodazole and rote-
none, increased free to polymerized tubulin ratios by more than8-fold, whereas paclitaxel, a microtubule stabilizer, decreased the free
to polymerized tubulin ratio and preventedmicrotubule depolymeriza-
tion by colchicine, nocodazole and rotenone (Fig. 6) [52]. Myxothiazol,
unlike rotenone, produced no change of the free to polymerized tubulin
ratio. Overall, free to polymerized tubulin ratios showed a strong in-
verse correlation with mitochondrial polarization.
In primary rat hepatocytes, free to polymerized tubulin ratios were
much smaller than in HepG2 hepatocarcinoma cells. Consistent with
these low ratios, microtubule stabilization with paclitaxel did not cause
hyperpolarization. However, depolymerization of microtubules with
nocodazole or colchicine caused mitochondrial depolarization [52].
3.6. Lack of change of plasma membrane potential after microtubule
depolymerization
Plasmalemmal potential also drives TMRM uptake into cells and ul-
timately into mitochondria. Thus, plasmalemmal hyperpolarization or
depolarization might increase or decrease cellular uptake of TMRM.
However as by monitored with DiBAC4(3) ﬂuorescence, plasmalemmal
potential did not change after exposure of HepG2 cells to colchicine,
nocodazole, or rotenone and does not account for loss of TMRM ﬂuores-
cence in the presence of microtubule-depolymerizing agents [52].
3.7. Regulation of tubulin-dependent changes of mitochondrial membrane
potential by protein kinase A and glycogen synthase-3β
PKA phosphorylates VDAC [9], and a recent single channel study
shows that PKA phosphorylation sensitizes VDAC to inhibition by tu-
bulin [72]. Similarly in intact HepG2 cells, the PKA agonist, dibutyryl
cAMP, caused mitochondrial depolarization, consistent with PKA aug-
mentation of tubulin-dependent VDAC closure (Fig. 5). Okadaic acid,
a protein phosphatase inhibitor that indirectly promotes phosphory-
lation, also depolarized mitochondria. By contrast, the PKA inhibitor,
H89, hyperpolarized mitochondria and prevented depolarization in-
duced by dibutyryl cAMP (Fig. 5). Moreover, H89 prevented and re-
versed the depolarizing effect of colchicine [52,72].
A recent study indicates that GSK3β-mediated phosphorylation
promotes VDAC opening [28]. Thus, GSK3β inhibition should promote
VDAC closure and mitochondrial depolarization. This expectation was
conﬁrmed with three structurally distinct GSK3β inhibitors, each of
which caused release of TMRM ﬂuorescence from HepG2 cells signify-
ing mitochondrial depolarization [52].
Taken together, these experiments support the conclusion that free
tubulin dynamically regulates mitochondrial function in cancer cells
through regulation of VDAC conductance. When tubulin increases, in-
creased VDAC closure occurs and mitochondrial function becomes sup-
pressed, as reﬂected by decreased mitochondrial ΔΨ. By contrast, as
free tubulin decreases, VDAC inhibition is lifted and mitochondrial me-
tabolism becomes enhanced. Thus in the steady state, both an increase
and a decrease of free tubulin will alter mitochondrial function. These
effects are further modulated by PKA, GSK3β and possibly other signal-
ing pathways implicated inWarburg metabolism. HIF-1α, for example,
upregulates glucose transporters, increases expression of several glyco-
lytic enzymes and inhibits pyruvate dehydrogenase via upregulation of
pyruvate dehydrogenase kinase (PDK) to contribute to the aerobic gly-
colysis of theWarburg effect [13,58,70], but howHIF-1αmaymodulate
tubulin-dependent VDAC closure remains to be determined.
3.8. Possible physiological role of tubulin regulation of voltage dependent
anion channels
As shown in yeast, aerobic glycolysis supports a higher rate of cell
growth than aerobic oxidative phosphorylation, and rapidly dividing
cells maintain a free tubulin reserve for spindle formation at mitosis.
Thus, high free tubulin is one signature of cell proliferation, but why
should tubulin have evolved as an inhibitor of VDAC and inducer of
Fig. 5.Modulation of mitochondrial membrane potential by free tubulin and protein kinase A. Pseudocolor of the ﬂuorescence of TMRM was used to monitor changes of mitochon-
drial ΔΨ in HepG2 human hepatoma cells. ΔΨ decreased after microtubule depolymerization with colchicine (Col) and nocodazole (Ncz). Paclitaxel (Ptx), a microtubule stabilizer,
hyperpolarized mitochondria even in the presence of nocodazole. Dibutyrl cAMP (cAMP), a PKA agonist, also depolarized mitochondria, whereas H89, a PKA inhibitor, hyperpolarized
mitochondria even in the presence of dibutyrl cAMP.
Adapted from [52].
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creased ATP supply during the energy-demanding events of chromo-
some separation and cytokinesis at mitosis. As the spindle apparatus
forms in prophase, free tubulin decreases. As a consequence, VDAC in-
hibition by tubulin is reversed, and aerobic ATP-generating mito-
chondrial metabolism becomes upregulated. In this way, tumor and
other rapidly proliferating cells may suspend Warburg metabolism
(aerobic glycolysis) in favor of oxidative phosphorylation to meet the
uniquely high bioenergetic demands of cell division. Then as microtu-
bules of the spindle apparatus depolymerize in telophase, free tubulin
increases and Warburg metabolism is restored.
4. Conclusions and future prospects
Overall, the ﬁndings reviewed here support the conclusion that
VDAC can dynamically regulate mitochondrial function as a kind of
adjustable governor, or governator, which limits maximal rates of mi-
tochondrial metabolism. In livers of animals exposed to ethanol,
VDAC closure in MOM and opening of a protonophoric uncoupling
pathway in MIM caused by aldehyde generation leads to selective
and more rapid oxidation of AcAld (Fig. 7). In cancer cells, high free
tubulin causes a relative closure of VDAC to suppress mitochondrial
function in Warburg metabolism, an effect augmented by PKA butFig. 6. Inverse relationship between free to polymerized tubulin and mitochondrial
membrane potential. Mitochondrial ΔΨ and free to polymerized tubulin were measured
after exposure of HepG2 cells to colchicine (Col), myxothiazol (Myxo), nocodazole
(Ncz), paclitaxel (Ptx) and rotenone (Rot) in various combinations.
Adapted from [52].
Fig. 7. Schemes of voltage dependent anion channel closure. In A, ethanol metabolism
by ADH and P450 2E1 generates AcAld, which promotes VDAC closure in MOM. P450
2E1 also generates ROS to cause lipid peroxidation and formation of MDA, which also
closes VDAC. Simultaneously in vivo, a proton-conducting uncoupling pathway opens
in MIM. These two events together promote increased mitochondrial respiration and
selective, more rapid oxidation and detoxiﬁcation of AcAld and MDA by ALDH. In B, ro-
tenone, colchicine and nocodazole increase free tubulin by depolmerizing microtu-
bules. Tubulin binds to and inhibits VDAC, which decreases uptake of respiratory
substrates and produces a relative mitochondrial depolarization. Paclitaxel stabilizes
microtubules, which promotes VDAC opening and mitochondrial hyperpolarization.
VDAC phosphorylation by PKA augments tubulin-dependent VDAC closure, whereas
GSK3β promotes opening. High free tubulin in tumor cells causes a relative closure of
VDAC, which suppresses mitochondrial metabolism and contributes to the Warburg
phenomenon of aerobic glycolysis.
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poised to increase or decrease as free tubulin decreases or increases.
Although not reviewed in detail here, VDAC closure seems to occur
in other settings, including metabolic suppression in early apoptosis
and suppression of mitochondrial ATP hydrolysis in ischemia
[28,87]. Other examples where VDAC closure may also be important
include the inhibition of respiration in the “cytopathic hypoxia” of
sepsis and hemorrhage/resuscitation and the inhibition of mitochon-
drial ATP release in unstimulated pancreatic beta cells [47,48]. Anoth-
er potentially beneﬁcial consequence of VDAC closure is blockade of
the release of toxic superoxide frommitochondria in conditions of ox-
idative stress [80].
The three different VDAC isoforms are widely distributed in vari-
ous tissues, which raises the possibility that the isoforms are differen-
tially regulated. For example, a speciﬁc isoform(s) but not others may
be responsible for suppression of the mitochondrial function in War-
burg metabolism or for decreased outer membrane permeability in
hepatocytes due to aldehydes. An intriguing possibility is that various
protein kinases act differentially on VDAC isoforms and that other
posttranslational modiﬁcations (e.g., acetylation) regulate VDAC. The
avenues for future research on VDAC are rich and diverse.
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